Search Results - "van Hilten, J J"

Risk factors for non-motor symptoms in Parkinson's disease by Marinus, Johan, Zhu, Kangdi, Marras, Connie, Aarsland, Dag, van Hilten, Jacobus J

“…Non-motor symptoms (NMS) of Parkinson's disease can be predominant as the disease advances, thereby constituting a major source of disease burden for patients…”
Get full text

Randomized Delayed-Start Trial of Levodopa in Parkinson’s Disease by Verschuur, Constant V.M, Suwijn, Sven R, Boel, Judith A, Post, Bart, Bloem, Bas R, van Hilten, Johannes J, van Laar, Teus, Tissingh, Gerrit, Munts, Alexander G, Deuschl, Guenther, Lang, Anthony E, Dijkgraaf, Marcel G.W, de Haan, Rob J, de Bie, Rob M.A

“…In a randomized, delayed-start trial of levodopa in Parkinson’s disease, with one group receiving the drug for 80 weeks and the other starting at 40 weeks, the…”
Get full text

Patient-reported autonomic symptoms in Parkinson disease by VERBAAN, D, MARINUS, J, VISSER, M, VAN ROODEN, S. M, STIGGELBOUT, A. M, VAN HILTEN, J. J

“…There is a wide range of autonomic symptoms (AS) in Parkinson disease (PD), but the full spectrum has never been evaluated with a validated instrument and in…”
Get full text

Clinical features and pathophysiology of complex regional pain syndrome by Marinus, Johan, Dr, Moseley, G Lorimer, Prof, Birklein, Frank, Prof, Baron, Ralf, Prof, Maihöfner, Christian, MD, Kingery, Wade S, MD, van Hilten, Jacobus J, Prof

“…Summary A complex regional pain syndrome (CRPS)—multiple system dysfunction, severe and often chronic pain, and disability—can be triggered by a minor injury,…”
Get full text

International study on the psychometric attributes of the Non-Motor Symptoms Scale in Parkinson disease by MARTINEZ-MARTIN, P, RODRIGUEZ-BLAZQUEZ, C, MIR, P, NAIDU, Y, NICOLETTI, A, SETHI, K, TSUBOI, Y, VAN HILTEN, J. J, VISSER, M, ZAPPIA, M, CHAUDHURI, K. R, ABE, K, BHATTACHARYYA, K. B, BLOEM, B. R, CAROD-ARTAL, F. J, PRAKASH, R, ESSELINK, R. A. J, FALUP-PECURARIU, C, GALLARDO, M

“…Nonmotor symptoms (NMS) have a great impact on patients with Parkinson disease (PD). The Non-Motor Symptoms Scale (NMSS) is an instrument specifically designed…”
Get full text

Gender-related differences in the burden of non-motor symptoms in Parkinson’s disease by Martinez-Martin, Pablo, Falup Pecurariu, Cristian, Odin, Per, van Hilten, Jacobus J., Antonini, Angelo, Rojo-Abuin, Jose M., Borges, Vanderci, Trenkwalder, Claudia, Aarsland, Dag, Brooks, David J., Ray Chaudhuri, Kallol

“…Differences in the expression of non-motor symptoms (NMS) by Parkinson’s disease (PD) patients may have important implications for their management and…”
Get full text

Inflammation in complex regional pain syndrome: A systematic review and meta-analysis by PARKITNY, Luke, MCAULEY, James H, DI PIETRO, Flavia, STANTON, Tasha R, O'CONNELL, Neil E, MARINUS, Johan, VAN HILTEN, Jacobus J, LORIMER MOSELEY, G

“…We conducted a systematic review of the literature with meta-analysis to determine whether complex regional pain syndrome (CRPS) is associated with a specific…”
Get full text

Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's disease by Mahlknecht, Philipp, Pechlaner, Raimund, Boesveldt, Sanne, Volc, Dieter, Pinter, Bernardette, Reiter, Eva, Müller, Christoph, Krismer, Florian, Berendse, Henk W., van Hilten, Jacobus J., Wuschitz, Albert, Schimetta, Wolfgang, Högl, Birgit, Djamshidian, Atbin, Nocker, Michael, Göbel, Georg, Gasperi, Arno, Kiechl, Stefan, Willeit, Johann, Poewe, Werner, Seppi, Klaus

“…ABSTRACT Introduction The aim of this study was to evaluate odor identification testing as a quick, cheap, and reliable tool to identify PD. Methods Odor…”
Get full text

Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA-AUT by Visser, Martine, Marinus, Johan, Stiggelbout, Anne M., Van Hilten, Jacobus J.

“…We developed a questionnaire to assess autonomic symptoms in patients with Parkinson's disease (PD) and evaluated its reliability and validity. Based on the…”
Get full text

Dopamine agonist therapy in early Parkinson's disease by Stowe, R L, Ives, N J, Clarke, C, van Hilten, J, Ferreira, J, Hawker, R J, Shah, L, Wheatley, K, Gray, R

“…Dopamine agonists are being used increasingly as first line treatment for Parkinson's disease, but there remains uncertainty about their clinical and…”
Get more information

Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose‐Driven Approach by Marras, Connie, Fereshtehnejad, Seyed‐Mohammad, Berg, Daniela, Bohnen, Nicolaas I., Dujardin, Kathy, Erro, Roberto, Espay, Alberto J., Halliday, Glenda, Van Hilten, Jacobus J., Hu, Michele T., Jeon, Beomseok, Klein, Christine, Leentjens, Albert F.G., Mollenhauer, Brit, Postuma, Ronald B., Rodríguez‐Violante, Mayela, Simuni, Tanya, Weintraub, Daniel, Lawton, Michael, Mestre, Tiago A.

“…The International Parkinson and Movement Disorder Society (MDS) created a task force (TF) to provide a critical overview of the Parkinson's disease (PD)…”
Get full text

A comprehensive model of health-related quality of life in Parkinson’s disease by Visser, M., van Rooden, S. M., Verbaan, D., Marinus, J., Stiggelbout, A. M., van Hilten, J. J.

“…Background Insight in how impairments and disabilities related to Parkinson’s disease (PD) influence health-related quality of life (HRQoL) is required to…”
Get full text

Parkinson's Disease Subtypes: Critical Appraisal and Recommendations by Mestre, Tiago A, Fereshtehnejad, Seyed-Mohammad, Berg, Daniela, Bohnen, Nicolaas I, Dujardin, Kathy, Erro, Roberto, Espay, Alberto J, Halliday, Glenda, van Hilten, Jacobus J, Hu, Michele T, Jeon, Beomseok, Klein, Christine, Leentjens, Albert F G, Marinus, Johan, Mollenhauer, Brit, Postuma, Ronald, Rajalingam, Rajasumi, Rodríguez-Violante, Mayela, Simuni, Tanya, Surmeier, D James, Weintraub, Daniel, McDermott, Michael P, Lawton, Michael, Marras, Connie

“…In Parkinson's disease (PD), there is heterogeneity in the clinical presentation and underlying biology. Research on PD subtypes aims to understand this…”
Get more information

Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS by Alexander, Guillermo M., van Rijn, M.A., van Hilten, J.J., Perreault, Marielle J., Schwartzman, Robert J.

“…Complex Regional Pain Syndrome (CRPS) Types I and II are characterized by various combinations of sensory, autonomic and motor abnormalities. Pain…”
Get full text

Cognitive impairment in Parkinson’s disease by Verbaan, D, Marinus, J, Visser, M, van Rooden, S M, Stiggelbout, A M, Middelkoop, H A M, van Hilten, J J

“…Background:Cognitive impairment plays a role in Parkinson’s disease (PD) and has important consequences for patient management. However, many aspects of…”
Get full text

Motor control in complex regional pain syndrome: A kinematic analysis by Schilder, J.C.M., Schouten, A.C., Perez, R.S.G.M., Huygen, F.J.P.M., Dahan, A., Noldus, L.P.J.J., van Hilten, J.J., Marinus, J.

“…CRPS patients perform repetitive finger movements slower and with more hesitations with both the affected hand and the unaffected hand, pointing at impaired…”
Get full text

Is olfactory impairment in Parkinson disease related to phenotypic or genotypic characteristics? by VERBAAN, D, BOESVELDT, S, VAN ROODEN, S. M, VISSER, M, MARINUS, J, MACEDO, M. G, FANG, Y, HEUTINK, P, BERENDSE, H. W, VAN HILTEN, J. J

“…To evaluate the relation between olfactory impairment (OI) and other impairment domains in Parkinson disease (PD) and the characteristics of OI in patients…”
Get full text

Fecal Microbiota Transplantation in Neurological Disorders by Vendrik, Karuna E W, Ooijevaar, Rogier E, de Jong, Pieter R C, Laman, Jon D, van Oosten, Bob W, van Hilten, Jacobus J, Ducarmon, Quinten R, Keller, Josbert J, Kuijper, Eduard J, Contarino, Maria Fiorella

“…Several studies suggested an important role of the gut microbiota in the pathophysiology of neurological disorders, implying that alteration of the gut…”
Get full text

Onset and evolution of anxiety in Parkinson's disease by Zhu, K., van Hilten, J. J., Marinus, J.

“…Background and purpose Anxiety is common in Parkinson's disease (PD) and has a great influence on quality of life. However, little is known about risk factors…”
Get full text

Assessment of cognition in Parkinson's disease by MARINUS, J, VISSER, M, VERWEY, N. A, VERHEY, F. R. J, MIDDELKOOP, H. A. M, STIGGELBOUT, A. M, VAN HILTEN, J. J

“…To develop a short, practical instrument that is sensitive to the specific cognitive deficits in Parkinson's disease (PD) for comparing groups in research…”
Get full text